Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Paragraph: Most lawmakers will spend the week in their home districts but a select few will gather in New York City for a hearing on what experts say is a looming crisis in home health care services. When the full Legislature returns Feb. 28, lawmakers can look forward to a month of backroom negotiations over the state budget. Democratic Gov. Andrew Cuomo has proposed a $152 billion spending plan. Lawmakers hope to agree on a final budget before April 1, the start of a new fiscal year. Another unresolved issue is Uber’s request to expand upstate. Ride-hailing services Uber and Lyft are both prohibited from operating outside of New York City. ___ This story has been corrected to show the home health care services hearing in in New York City, not Albany. Claim: This Week from Albany: Break before budget work.
In New York state government news, the Legislature is taking a break before work on the state budget heats up.

Paragraph: No mention of the cost of treatment. This is important if the surgery is not a permanent fix for acute sinusitis. Repeated operations and continued medications need to be compared to cost for traditional surgery. No quantitative estimate of the benefits of the new procedure. There was a study of 10 people that found “no safety concerns”, but readers should be told more about this very small group. What were the long term outcomes and did these patients eventually have to have further sinuplasty, more invasive surgery or continue to take medications to relieve sinusitits? The story mentions that a larger, randomized trial is underway to better understand the risks and benefits of sinuplasty compared to medication and traditional sinus surgery. Mentions that more information is needed and no one knows if balloon sinuplasty works as well as the more traditional surgical option for chronic sinusitis. Mentions that general anesthesia is still needed for balloon procedure and this comes with its own set of health risks. There isn’t much evidence for the story to report. The story did stress the importance of a randomized trial underway comparing medication, traditional sinus surgery and the newer balloon sinuplasty. Story describes this trial and the need for further evidence before this new procedure can be widely recommended. Mentions that this procedure should not have been FDA approved with so little quality evidence. No evidence of disease mongering. The story mentions that this procedure would be for chronic, not acute sinunitis and describes how these are different. Good balance of information on treatment options with input from otolaryngologists not affliated with the makers of the device who are able to provide perspective on the new procedure. They mention that further study is needed. There is a note that one of the physicans studying the new sinuplasty has no financial ties to Acclarent, maker of the balloon devices used in this type of sinuplasty. Mentions that this form of sinuplasty is not for everybody and that it may not prevent the need for more comprehensive surgery in which bone and tissue are removed. There is mention of other options including medication and the more traditional surgery, which is decribed as highly effective, but with a painful recovery and side effects such as scar tissue. Quantification of the incidence of this and other side effects of traditional surgery would be useful. The story is clear that the FDA approved the device but that it still needs to undergo further study via randomized controlled trials. Story mentions that this is a new procedure only offerred by 100 doctors. This story is a blananced presentation of sinuplasty and the information here does not appear to be from a press release. The are quotes from otolaryngologists not affliated with the makers of the device who are able to provide perspective on the new sinuplasty procedure. Claim: A balloon instead of a knife: Sinuplasty for ailing sinuses
This story provides a good balance of information on a new treatment option for chronic sinusitis, and there is corroboration with otolaryngologists not affiliated with the makers of the balloon device who are able to provide perspective on the procedure. The story clearly notes this procedure would be for chronic, not acute sinusitis and describes how these are different. The story explains that this form of sinuplasty is not for everybody, and that it may not prevent the need for more comprehensive surgery in which bone and inflamed tissue are removed to open the sinus passages. More information is needed on the safety and efficacy of balloon sinuplasty, and no one knows if this surgery works as well as traditional surgery for chronic sinusitis. The story mentions other options for treating chronic sinusitis, including medication and sinus surgery, which is described as highly effective, but with a painful recovery and side effects such as scar tissue. Quantification of the incidence of side effects with traditional surgery would be useful. While there is not much quantitative evidence available on the new procedure, the story stresses the importance of a randomized trial underway comparing medication, traditional sinus surgery and the newer balloon sinuplasty. There is adequate description of this trial and the need for further evidence before this new procedure can be widely recommended. There is a caveat that this procedure should not have been FDA approved with so little quality evidence: a study of 10 people that found “no safety concerns”, but readers should be told more about this very small group. What were the long term outcomes and did these patients eventually have to undergo further sinuplasty, more invasive surgery or continue to take medications to relieve their chronic sinusitis? The story explains that general anesthesia is still needed for the balloon procedure and this comes with its own set of health risks and additional costs. There is no mention of the cost of this newer procedure. This is important information if the surgery is not a permanent fix for chronic sinusitis. A cost comparison of the newer sinuplasty, which may require repeated operations, sinus medications and traditional surgery is needed.

Paragraph: The step was one of a series announced by Chinese drug regulators to improve access to treatments and streamline an approval process that foreign suppliers complain is too slow and complex. The communist government is in the midst of a marathon effort to expand access to health care for China’s 1.4 billion people. At the same time, it faces pressure from trading partners to open its markets for medical technology. Regulators want to improve access to “urgently needed drugs and medical devices,” the CFDA said in a statement. “Regarding drugs and medical devices that already are approved to go on the market abroad, they will be allowed on the market with conditions attached,” the agency said. The agency gave no details of what products might be affected or how the approval process would work. Suppliers of drugs and devices such as X-ray machines have long looked at China as a promising market but complain that a cumbersome approval process that can take up to seven years hampers market access. In 2015, the CFDA promised to simplify drug approvals and clear a backlog of applications. Despite such steps, suppliers say Beijing is backtracking in some areas, such as by excluding foreign products from catalogs used by hospitals to purchase medical equipment. Also Monday, the CFDA said it would streamline the process for approving generic drugs, a step that could undercut potential demand for foreign products. Claim: China to allow some drugs based on foreign approvals.

China will allow use of some drugs and medical devices based on approval by foreign regulators, the government said Monday, in a move that could help to ease access to its health care market.